Alteration of follicle-stimulating hormone and testosterone regulation of messenger ribonucleic acid for Sertoli cell proteins in the rat during the acute phase of spinal cord injury
Je. Ottenweller et al., Alteration of follicle-stimulating hormone and testosterone regulation of messenger ribonucleic acid for Sertoli cell proteins in the rat during the acute phase of spinal cord injury, BIOL REPROD, 63(3), 2000, pp. 730-735
The detrimental effects of spinal cord injury (SCI) on spermatogenesis in t
he rat can be attenuated by exogenous testosterone (T) but enhanced by exog
enous follicle-stimulating hormone (FSH). These results suggest that T-depe
ndent cellular events may be involved in testicular injury after SCI and th
at such events may be associated with modification of FSH effects on Sertol
i cell function. The current study compared the responses of Sertoli cells
to exogenous T and FSH after SCI or sham surgery using steady-state levels
of Sertoli cell protein mRNA transcripts as markers of responsiveness. Rats
underwent sham surgery or SCI and then were treated for 7 or 14 days with
T-filled silastic capsules (2 x 5 cm) and/or daily injections of 0.1 units
of porcine FSH. Vehicle-treated control rats received 5-cm empty capsules a
nd daily injections of saline vehicle. Two weeks after sham surgery, levels
of mRNA for the androgen receptor (AR), FSH receptor (FSHR), androgen-bind
ing protein (ABP), or sulfated glycoprotein (SGP)-2 in the testis were unaf
fected by T or FSH alone. Testosterone alone, however, significantly decrea
sed transferrin (Trf) mRNA levels in the testis (P < 0.01). The combination
of T and FSH treatments resulted in significant decreases in levels of the
above transcripts (P < 0.05; P < 0.01). Seven days after SCI, the testes o
f vehicle-treated SCI rats had higher levels of AR and SGP-2 mRNA than did
those of sham control rats (P < 0.01); such effects were transient and disa
ppeared by Day 14 post-SCI. Testosterone treatment of SCI rats for 7 days r
esulted in decreases in mRNA levels for AR and Trf in the testes (P < 0.01)
but increased testicular levels of mRNAs for FSHR and SGP-2 in SCI rats. F
ollicle-stimulating hormone treatment for 7 days prevented the increase in
AR mRNA that was seen in the testis of untreated SCI rats and increased lev
els of ABP and SGP-2 mRNAs in SCI rats (P < 0.01). Follicle-stimulating hor
mone treatment of SCI rats did not affect FSHR mRNA levels by itself, but i
t blocked the stimulatory effect of T on FSHR and SGP-2 mRNAs. Fourteen day
s after SCI, testicular AR mRNA levels were not affected by T alone, but th
ey increased in those rats that received FSH with or without concurrent T t
reatments (P < 0.05). In contrast to their effects in sham control rats, T
or FSH alone or in combination resulted in significant increases in testicu
lar levels of ABP, SGP-P, and FSHR mRNAs (P < 0.05). At this time, Trf mRNA
in the testis of SCI rats was also suppressed by T (P < 0.05), as it did i
n sham control rats, but Trf mRNA was increased by the FSH (P < 0.01) that
had inhibited this transcript in the testes of sham control rats. The effec
ts of FSH on the Sertoli cell transcripts in SCI rats were either attenuate
d or blocked when T was given concurrently. In addition, testicular and ser
um T levels in those SCI rats that received FSH (alone or in combination wi
th T) for 14 days were significantly increased, an effect that was not seen
after sham surgery. These findings demonstrate that hormonal regulation of
both Sertoli and Leydig cells was altered during the acute phase of SCI. S
uch changes may modify the functions of both cell types, thereby affecting
the endocrine and/or paracrine microenvironment within the seminiferous epi
thelium. These effects could impair the functional capacity of Sertoli cell
s and contribute to impairment of spermatogenesis after SCI.